✦ LIBER ✦

Clinical trial design in head and neck cancer: what has the oncologist learned?

✍ Scribed by David J Adelstein

Book ID: 117786036
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 208 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70119-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

K2. Clinical trial design in head and ne

K2. Clinical trial design in head and neck cancer: Lessons learned and challenges for the future

✍ David J. Adelstein 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Clinical trials of radiation sensitizers

Clinical trials of radiation sensitizers in Head and neck cancer

✍ Andrew R. Harwood(C) 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Clinical Trials on Uft in the Treatment

Clinical Trials on Uft in the Treatment of Head and Neck Cancer

✍ Tanaka, Juichi; Inuyama, Yukio; Fujii, Masato; Takaoka, Tetsuro; Hosoda, Hyonosu 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 451 KB

Impact of HPV-Related Head and Neck Canc

Impact of HPV-Related Head and Neck Cancer in Clinical Trials

✍ Chung, Christine H.; Schwartz, David L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Expanding Role of the Medical Oncologist

Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer

✍ Dr. Nicholas Choong; Dr. Everett Vokes 📂 Article 📅 2008 🏛 American Cancer Society 🌐 English ⚖ 432 KB

Clinical trials with fluorinated pyrimid

Clinical trials with fluorinated pyrimidines in patients with head and neck cancer

✍ Muhyi Al-Sarraf 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 851 KB

While it is estimated to be one of the most prevalent cancers in the world, cancer of the head and neck is an uncommon malignant tumor in the United States and accounts for only 5% of all malignancies [1]. Head and neck cancer is a term that encompasses heterogeneous groups of patients. The most com